Epitomee Medical Ltd (TLV:EPIT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
851.40
+21.10 (2.54%)
Jun 26, 2025, 5:24 PM IDT
142.56%
Market Cap 243.69M
Revenue (ttm) n/a
Net Income (ttm) -5.33M
Shares Out 29.59M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,190
Average Volume 13,344
Open 819.30
Previous Close 830.30
Day's Range 819.30 - 850.00
52-Week Range 249.40 - 1,570.00
Beta 0.81
RSI 50.40
Earnings Date Aug 14, 2025

About Epitomee Medical

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 42
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol EPIT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.